Genome-wide KO CRISPR-Cas9 screen on Haploid human embryonic stem cells with TP53 or MLH1 LoF
Haploid human embryonic stem cells harboring TP53 or MLH1 knockout (KO) were subjected to a genome-wide CRISPR-Cas9 knockout screen to identify synthetic lethal interactions associated with the mentioned genes.